I am pleased to announce that effective January 1, 2016, Frances “Fran” Zipp is President & Chief Executive Officer of Lachman Consultants. Fran previously served as President of Consulting Operations since joining Lachman Consultants in March 2014, following a successful career in the industry serving senior global quality and compliance roles at major pharmaceutical and biologic companies, including, but not limited to Wyeth Laboratories and Teva Pharmaceuticals.
Fran is now the most senior executive officer of Lachman Consultants, responsible for all aspects of running the business. She also continues to serve as a key member of its Board of Directors and member of its Executive Committee. Although no longer CEO, I will continue to serve as Chairman of the Board of Directors and, as appropriate, provide guidance and support to Fran and her team as they continue to serve the needs of our worldwide clientele. I look forward to working with Fran in her new position and engaging with our valued clients.